Page last updated: 2024-08-23

flunixin meglumine and Angiogenesis, Pathologic

flunixin meglumine has been researched along with Angiogenesis, Pathologic in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Baghel, KS; Bhadauria, S; Bhatt, ML; Dubey, P; Jain, NK; Kumar, V; Lone, MU; Misra, S; Shrivastava, R; Tewari, BN; Tripathi, C	1

Other Studies

1 other study(ies) available for flunixin meglumine and Angiogenesis, Pathologic

Article	Year
Cyclooxygenase-2 inhibition attenuates hypoxic cancer cells induced m2-polarization of macrophages. Cellular and molecular biology (Noisy-le-Grand, France), 2014, Sep-12, Volume: 60, Issue:3 Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Breast Neoplasms; Cell Hypoxia; Cell Line, Tumor; Chick Embryo; Chorioallantoic Membrane; Clonixin; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Female; Humans; Macrophages; Neovascularization, Pathologic; Up-Regulation; Vascular Endothelial Growth Factor A	2014

Article

Year

Cyclooxygenase-2 inhibition attenuates hypoxic cancer cells induced m2-polarization of macrophages.

Cellular and molecular biology (Noisy-le-Grand, France), 2014, Sep-12, Volume: 60, Issue:3

Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Breast Neoplasms; Cell Hypoxia; Cell Line, Tumor; Chick Embryo; Chorioallantoic Membrane; Clonixin; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Female; Humans; Macrophages; Neovascularization, Pathologic; Up-Regulation; Vascular Endothelial Growth Factor A

2014